FDA Approves Treatment for Alzheimer’s Disease
The US Food and Drug Administration (FDA) on Tuesday approved Kisunla (donanemab-azbt) injection, produced by Eli Lilly, for the treatment of Alzheimers disease. Kisunla is the third amyloid-targeting drug approved…